Evidence map›Paper›PMID 35798905›Full record

ArticleCell biology and toxicology2023

SIRT6 regulates obesity-induced oxidative stress via ENDOG/SOD2 signaling in the heart.

Shuya Gao, Qingchen Yang, Yue Peng, Weixian Kong, Zekun Liu, Zhe Li, Jiawen Chen, Mengmeng Bao, Xie Li, Yubin Zhang and 7 more

Abstract read
PubMed Publisher
In one paragraph

Article in Cell biology and toxicology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 2 countries.

Shuya Gao *Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, Nanjing, 210006, China.
Qingchen Yang *Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, Nanjing, 210006, China.
Yue Peng *School of Life Science and Technology, China Pharmaceutical University, Nanjing, 210006, China.
Weixian KongSchool of Life Science and Technology, China Pharmaceutical University, Nanjing, 210006, China.
Zekun LiuSchool of Life Science and Technology, China Pharmaceutical University, Nanjing, 210006, China.
Zhe LiDepartment of Cardiology, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Jiawen ChenResearch Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, Nanjing, 210006, China.
Mengmeng BaoSchool of Life Science and Technology, China Pharmaceutical University, Nanjing, 210006, China.
Xie LiSchool of Life Science and Technology, China Pharmaceutical University, Nanjing, 210006, China.
Yubin ZhangSchool of Life Science and Technology, China Pharmaceutical University, Nanjing, 210006, China.
Xiaohong BianSchool of Life Science and Technology, China Pharmaceutical University, Nanjing, 210006, China.
Liang JinSchool of Life Science and Technology, China Pharmaceutical University, Nanjing, 210006, China.
Hanwen ZhangSchool of Life Science and Technology, China Pharmaceutical University, Nanjing, 210006, China.
Yuexin ZhangSchool of Life Science and Technology, China Pharmaceutical University, Nanjing, 210006, China.
Daniel SanchisInstitut de Recerca Biomedica de Lleida (IRBLLEIDA), Universitat de Lleida, Edifici Biomedicina-I, Av. Rovira Roure 80, 25198, Lleida, Spain. daniel.sanchis@udl.cat.
Fangrong YanResearch Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, Nanjing, 210006, China. f.r.yan@163.com.
Junmei YeSchool of Life Science and Technology, China Pharmaceutical University, Nanjing, 210006, China. junmeiye@cpu.edu.cn.
China Pharmaceutical University · CNBiomedical Research Institute of Lleida · ESRenmin Hospital of Wuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The sirtuin 6 (SIRT6) participates in regulating glucose and lipid homeostasis. However, the function of SIRT6 in the process of cardiac pathogenesis caused by obesity-associated lipotoxicity remains to be unveiled. This study was designed to elucidate the role of SIRT6 in the pathogenesis of cardiac injury due to nutrition overload-induced obesity and explore the downstream signaling pathways affecting oxidative stress in the heart. In this study, we used Sirt6 cardiac-specific knockout murine models treated with a high-fat diet (HFD) feeding to explore the function and mechanism of SIRT6 in the heart tissue during HFD-induced obesity. We also took advantage of neonatal cardiomyocytes to study the role and downstream molecules of SIRT6 during HFD-induced injury in vitro, in which intracellular oxidative stress and mitochondrial content were assessed. We observed that during HFD-induced obesity, Sirt6 loss-of-function aggravated cardiac injury including left ventricular hypertrophy and lipid accumulation. Our results evidenced that upon increased fatty acid uptake, SIRT6 positively regulated the expression of endonuclease G (ENDOG), which is a mitochondrial-resident molecule that plays an important role in mitochondrial biogenesis and redox homeostasis. Our results also showed that SIRT6 positively regulated superoxide dismutase 2 (SOD2) expression post-transcriptionally via ENDOG. Our study gives a new sight into SIRT6 beneficial role in mitochondrial biogenesis of cardiomyocytes. Our data also show that SIRT6 is required to reduce intracellular oxidative stress in the heart triggered by high-fat diet-induced obesity, involving the control of ENDOG/SOD2.

Indexed as

Oxidative StressSirtuinsAnimalsEndodeoxyribonucleasesLipidsMiceObesitySuperoxide Dismutase 2Endodeoxyribonucleasesendonuclease GLipidsSirt6 protein, mouseSirtuinsSuperoxide Dismutase 2Endonuclease GHigh-fat dietOxidative stressSirtuin 6Superoxide dismutase 2

Identifiers

PMID35798905
OpenAlexW4284894107

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.